Showing results (571-580 of 1,919) with videos related to
Sort By:
Pageof 192
Cancer Biomarkers : Section a of Disease Markers|April 4, 2025
BUB1, miR-495-3p, and E2F1/E2F8 axis is associated with poor prognosis of breast cancer patients and infiltration of Th2 cells in the tumor microenvironmentRajeev Nema, Ashok KumarCancer Biomarkers : Section a of Disease Markers|October 11, 2024
Identification of RNA-binding protein RBMS3 as a potential biomarker for immunotherapy in bladder cancerTarimo Fredrick Praygod, Jinlong Li, Hongwei Li, et al.Cancer Biomarkers : Section a of Disease Markers|September 27, 2024
Uncovering the link between human endogenous retroviruses, inflammatory pathways, and gastric cancer developmentZhengtai Li, Hongjiang Li, Kun Fang, et al.Cancer Biomarkers : Section a of Disease Markers|September 27, 2024
Blood endocan as a biomarker for breast cancer recurrenceKentaro Daiki, Yoko Kanada, Aya Nagata, et al.Cancer Biomarkers : Section a of Disease Markers|September 6, 2024
RANK in cancer-associated fibroblasts: A valuable prognostic determinant for metastasis in early-stage breast cancer patientsMaría Belén Giorello, Francisco Raúl Borzone, María Florencia Mora, et al.Cancer Biomarkers : Section a of Disease Markers|September 13, 2024
Circulating tumor DNA (ctDNA) as a biomarker of response to therapy in advanced Hepatocellular carcinoma treated with NivolumabYehia I Mohamed, Sunyoung S Lee, Tarik Demir, et al.Cancer Biomarkers : Section a of Disease Markers|February 20, 2025
GABPα inhibits tumor progression and angiogenesis via a novel 18-bp indel within VEGF promoter in breast cancerHui Guo, Yue Han, Qiaoyi Zhou, et al.Cancer Biomarkers : Section a of Disease Markers|August 30, 2024
Glutaminase 1 plays critical roles in myelodysplastic syndrome and acute myeloid leukemia cellsSeiichi Okabe, Mitsuru Moriyama, Yuya Arai, et al.Cancer Biomarkers : Section a of Disease Markers|February 1, 2007
SELDI-TOF MS serum protein profiles in breast cancer: assessment of robustness and validityM C W Gast, J M G Bonfrer, E J van Dulken, et al.Cancer Biomarkers : Section a of Disease Markers|February 1, 2007
Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) for determining prognosis in advanced stage hormone relapsing prostate cancerManish Kohli, Eric Siegel, Sudeepa Bhattacharya, et al.Pageof 192